Fem dophilus 1 billion CFUFem Dophilus contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR 1 and Limosilactobacillus reuteri RC 14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR 1 and RC 14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem Dophilus from